Level D· Scientific groundwork from lab and animal studiesLaboratory StudyEurope PMCOpen access

Adipose Tissue in Persons With HIV Is Enriched for CD4 + T Effector Memory and T Effector Memory RA + Cells, Which Show Higher CD69 Expression and CD57, CX3CR1, GPR56 Co-expression With Increasing Glucose Intolerance

Wanjalla CN., McDonnell WJ., Barnett L., Simmons JD., Furch BD., Lima MC.

Laboratory Study with a reported sample of 9 on Systemic / IV, published in Front Immunol (2019) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Front Immunol (2019)
Reported sample size
9
Source database
Europe PMC
PMID
30941121
PMCID
PMC6433850
DOI
10.3389/fimmu.2019.00408
Citations
47

Abstract (original English)

Chronic T cell activation and accelerated immune senescence are hallmarks of HIV infection, which may contribute to the increased risk of cardiometabolic diseases in people living with HIV (PLWH). T lymphocytes play a central role in modulating adipose tissue inflammation and, by extension, adipocyte energy storage and release. Here, we assessed the CD4 + and CD8 + T cell profiles in the subcutaneous adipose tissue (SAT) and blood of non-diabetic ( n = 9; fasting blood glucose [FBG] n = 8; FBG = 100-125 mg/dL) and diabetic ( n = 9; FBG ≥ 126 mg/dL) PLWH, in addition to non- and pre-diabetic, HIV-negative controls ( n = 8). SAT was collected by liposuction and T cells were extracted by collagenase digestion. The proportion of naïve (T Nai ) CD45RO - CCR7 + , effector memory (T EM ) CD45RO + CCR7 - , central memory (T CM ) CD45RO + CCR7 + , and effector memory revertant RA + (T EMRA ) CD45RO - CCR7 - CD4 + and CD8 + T cells were measured by flow cytometry. CD4 + and CD8 + T EM and T EMRA were significantly enriched in SAT of PLWH compared to blood. The proportions of SAT CD4 + and CD8 + memory subsets were similar across metabolic status categories in the PLWH, but CD4 + T cell expression of the CD69 early-activation and tissue residence marker, particularly on T EM cells, increased with progressive glucose intolerance. Use of t-distributed Stochastic Neighbor Embedding (t-SNE) i

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adipose TissueT-Lymphocyte SubsetsCD4-Positive T-LymphocytesHumansHIV InfectionsGlucose IntoleranceLectins, C-TypeReceptors, G-Protein-CoupledAntigens, CDAntigens, Differentiation, T-Lymphocyte

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research